GLP-1RAs have transformed the treatment landscape for diabetes and obesity, making them promising candidates for MASLD
Williams LM, Debattista C, Duchemin AM, Schatzberg AF, Nemeroff CB
A review of Diabetic Gastroparesis found that the class of drugs known as glucagon-like peptide 1 (GLP-1) receptor agonists such as dulaglutide (Trulicity) may exacerbate the symptoms of diabetic gastroparesis and therefore are not recommended for individuals experiencing symptoms of gastroparesis
ClinicalTrials.gov search: retatrutide.
If your compounded tirzepatide arrives as a lyophilized (freeze-dried) powder that requires reconstitution with bacteriostatic water , the reconstituted solution has different stability characteristics than the original powder
WeightWatchers Clinic Weight Watchers merges medical weight loss via GLP-1s with the proven behavioral tools made famous by the Weight Watchers of Oprah Winfreys day